374. Venture: What MVM Partners Really Wants in a MedTech Company with Kyle Dempsey

In this episode, Omar Khateeb sits down with Kyle Dempsey, Partner at MVM Partners, to unpack what makes a medtech company investable. Kyle shares how MVM evaluates opportunities, why commercial traction matters, and what separates strong companies from those that get overlooked. They also explore how strategics think about acquisitions, why differentiation and market size matter, and how investors assess risk across the commercialization journey. If you want a clearer understanding of medtech investing, commercialization, and exits, this episode delivers exactly that.Episode Breakdown:00:00 Why MedTech Wins: Innovation vs Big Strategics01:04 Intro + Kyle Dempsey (MVM) Background02:13 Journey: From Medical School to Investing06:50 What is MVM and How the Fund Evolved09:41 Portfolio Highlights + Biggest Wins10:59 Fund Strategy: High Conviction Investing12:24 What MVM Avoids: DTC and Weak Models13:58 Why Most MedTech Startups Fail 16:22 DTC vs B2B Economics in Healthcare17:25 Why Esthetics is a Tough Category19:12 What Makes a Great MedTech Company23:03 Evaluating Competitive Markets25:49 Winning in Competitive Categories27:38 Sales Model + Market Size Reality29:01 Why Big Markets Attract Acquirers30:56 MedTech Exit Trends + M&A Outlook33:44 IPO Market vs Acquisition Strategy36:58 What LPs Care About (DPI vs IRR)40:07 Fast Returns vs Long-Term Outcomes41:41 Why Traction Matters More Than Ever44:33 Bad MedTech Models That Still Get Funded46:20 Small Markets vs Scalable Opportunities48:37 TAM vs SAM vs Real Market Potential51:35 BCI and Neurotech: Hype vs Reality55:48 MVM Investment Stage + Check Size01:00:28 AI in MedTech: Feature vs Platform01:04:25 AI Business Model Challenges01:07:30 Final Thoughts + Future of MedTechAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #venturecapital #healthcareinnovation #startupstrategy #medicaldevices